Brief: Option Care Health Selected For VYJUVEK By Krystal Biotech
23/05/2023 22:43
May 23 (Reuters) - Krystal Biotech Inc KRYS.O :
* OPTION CARE HEALTH INC-ANNOUNCED THAT IT WAS SELECTED BY
KRYSTAL
BIOTECH, INC AS PART OF LIMITED DISTRIBUTION SPECIALTY PHARMACY
NETWORK FOR VYJUVEK
Source text for Eikon: ID:nGNX4vhk25
Further company coverage: KRYS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion